ImmuneID Announces Close of $50 Million Series A Financing to Develop Precision Immunology Therapeutics June 23, 2021
GRAIL Presents Interventional PATHFINDER Study Data and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test June 4, 2021
Pulmocide Raises $92 Million in a Series C Financing to Fund Registration Program for PC945 May 27, 2021
